These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10867843)

  • 1. Treatment and prevention of respiratory syncytial virus infection.
    Kneyber MC; Moll HA; de Groot R
    Eur J Pediatr; 2000 Jun; 159(6):399-411. PubMed ID: 10867843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for respiratory tract infections caused by respiratory syncytial virus.
    van Woensel J; Kimpen J
    Eur J Pediatr; 2000 Jun; 159(6):391-8. PubMed ID: 10867842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus disease: update on treatment and prevention.
    Krilov LR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of respiratory syncytial virus infection.
    Kimpen JL
    Curr Opin Infect Dis; 2001 Jun; 14(3):323-8. PubMed ID: 11964851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment.
    Van Woensel JB; Kimpen JL; Brand PL
    Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA; Cosgrove JF; MacMahon P
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery.
    Ottolini MG; Hemming VG
    Drugs; 1997 Dec; 54(6):867-84. PubMed ID: 9421694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus infections: characteristics and treatment.
    Chidgey SM; Broadley KJ
    J Pharm Pharmacol; 2005 Nov; 57(11):1371-81. PubMed ID: 16259768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and prevention options for respiratory syncytial virus infections.
    Levin MJ
    J Pediatr; 1994 May; 124(5 Pt 2):S22-7. PubMed ID: 8169754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of infections caused by respiratory syncytial virus.
    Swedish Consensus Group
    Scand J Infect Dis; 2001; 33(5):323-8. PubMed ID: 11440215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive and therapeutic strategies for respiratory syncytial virus infection.
    Vujovic O; Mills J
    Curr Opin Pharmacol; 2001 Oct; 1(5):497-503. PubMed ID: 11764776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity.
    Broughton S; Greenough A
    Expert Opin Pharmacother; 2003 Oct; 4(10):1801-8. PubMed ID: 14521489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts on active immunization against respiratory syncytial virus for infants and young children.
    Kneyber MC; Kimpen JL
    Pediatr Infect Dis J; 2002 Jul; 21(7):685-96. PubMed ID: 12237605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    Meissner HC; Long SS;
    Pediatrics; 2003 Dec; 112(6 Pt 1):1447-52. PubMed ID: 14654628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of respiratory syncytial virus with lower respiratory tract infection in infants and children.
    Garzon LS; Wiles L
    AACN Clin Issues; 2002 Aug; 13(3):421-30. PubMed ID: 12151995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pharmacological aspects of immunoprophylaxis for respiratory syncytial virus infection in high-risk infants.
    Lanari M; Silvestri M; Rossi GA
    Curr Drug Metab; 2013 Feb; 14(2):216-25. PubMed ID: 22935064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn.
    Pediatrics; 1998 Nov; 102(5):1211-6. PubMed ID: 9794957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for control of respiratory syncytial virus infection.
    Nokes JD; Cane PA
    Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.